Ergomed appoints Roy Ovel

 Ergomed plc, a company focused on providing specialised services to the pharmaceutical industry, today announces the appointment of Roy Ovel as Chief Commercial Officer with immediate effect.

He brings to Ergomed over 30 years’ experience in international business development. This has included roles with larger CROs such as ICON, TFS and Worldwide Clinical Trials as well as with local, specialist CROs. At TFS International, Roy was responsible for global sales and marketing for more than four years, including leadership of the global marketing team.

Roy Ovel will join Ergomed’s Executive team and will be responsible for global sales and business development activities across the Company’s full services offering.

Dr Miroslav Reljanović, Executive Chairman of Ergomed, commented: “Roy brings a wealth of experience to Ergomed. He has a proven track record in building commercial success through an understanding of customer’s needs and delivering growth. I am confident that operating across the Ergomed business he will make a significant contribution to the Company through the services we provide our clients.”